NCT00411125

Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women

A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled Crossover Phase I Study Assessing Pharmacokinetics and Pharmacodynamics of Two Different SMC021 0.8 mg Variants and the Effect of Timing of Drug Intake in Healthy Postmenopausal Women

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 86 (planned)
• Sponsor: Novartis · Industry
• Sex: Female
• Age: 40 Years – 70 Years
• Healthy volunteers: —

Summary

This is a phase I study to analyze bioavailability and pharmacodynamic of two different variants of oral salmon calcitonin (SMC021) in postmenopausal women

Conditions

• Postmenopausal Osteoporosis

Interventions

Type	Name	Description
DRUG	Oral salmon calcitonin

Timeline

• Start date: 2006-08-01
• Completion: 2006-11-01
• First posted: 2006-12-13
• Last updated: 2006-12-13

Locations

1 site across 1 country: Denmark